JEST
PRME icon

JTC Employer Solutions Trustee’s Prime Medicine PRME Stock Holding History

JTC Employer Solutions Trustee’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$46K Hold
13,249
– – ﹤0.01% 244
2025
Q4 		$46K Hold
13,249
– – ﹤0.01% 250
2025
Q3 		$73K Hold
13,249
– – 0.01% 226
2025
Q2 		$33K Buy
+13,249
New +$20.4K ﹤0.01% 247

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

JTC Employer Solutions Trustee's PRME Position: Q1 2026 in Review

JTC Employer Solutions Trustee held its Prime Medicine (PRME) position steady in Q1 2026 at 13,249 shares worth $46K. The position accounts for ﹤0.01% of the portfolio, ranked #244.

JTC Employer Solutions Trustee first reported a position in PRME in Q2 2025 and has held it in 4 quarters since. The position peaked at $73K in Q3 2025. 192 funds tracked by Wall St. Rank hold PRME as of Q1 2026.

  • JTC Employer Solutions Trustee held 13,249 shares of Prime Medicine worth $46K as of Q1 2026.
  • JTC Employer Solutions Trustee left its Prime Medicine share count unchanged in Q1 2026.
  • Prime Medicine made up ﹤0.01% of JTC Employer Solutions Trustee's portfolio in Q1 2026, its #244 holding.
  • JTC Employer Solutions Trustee first reported a position in Prime Medicine in Q2 2025 and has held it in 4 quarters since.
  • JTC Employer Solutions Trustee's Prime Medicine position peaked at $73K in Q3 2025.
  • 192 funds tracked by Wall St. Rank held Prime Medicine as of Q1 2026.

Based on JTC Employer Solutions Trustee's 13F filing for Q1 2026, filed 19 May 2026.